Genus Capital Management’s Cardinal Health CAH Stock Holding History

Genus Capital Management’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.09M	Buy	+38,270	New	+$7.95M	0.89%	35

Other funds holding CAH

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Genus Capital Management's CAH Position: Q2 2026 in Review

Genus Capital Management opened a new position in Cardinal Health (CAH) in Q2 2026: 38,270 shares worth $9.09M. The stake represents 0.89% of the portfolio and ranks #35 among its holdings.

760 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Genus Capital Management held 38,270 shares of Cardinal Health worth $9.09M as of Q2 2026.
Cardinal Health was a new Genus Capital Management position in Q2 2026.
Cardinal Health made up 0.89% of Genus Capital Management's portfolio in Q2 2026, its #35 holding.
760 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.